FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

6 letters match. Newest first.

  1. Koven Technologies, Inc.

    FDA warns Koven Technologies that its Bidop 3 Doppler was labeled for fetal use without clearance and had quality system violations.

    High risk
  2. WHOOP, Inc.

    FDA warns WHOOP it markets Blood Pressure Insights without device clearance or approval.

    High risk
  3. Anne’s Daye Ltd dba Tampon Innovations

    FDA says Anne’s Daye marketed CBD-coated tampons and vaginal screening kits without required device clearance or approval.

    High risk
  4. Adventure Innovations LLC

    FDA says Adventure Innovations sold Sani Bot D3, a CPAP cleaner, without device clearance or approval.

    Medium
  5. Marci Beauty LLC

    Marci Beauty markets seven light therapy devices without FDA clearance or approval, with claims to treat serious diseases.

    High risk
  6. Shenzhen Sunell Technology Corporation

    FDA warns Shenzhen Sunell over unapproved COVID-19 fever-screening cameras sold in U.S. without clearance.

    High risk